Article

Caffeine Doesn't Bring on Atrial Fibrillation, Arrhythmias, Study Finds

Author(s):

Despite decades of clinical advice that caffeine is bad for the heart, there has been little actual study of its effects. A California team said moderate consumption does not affect the performance of the heart or trigger arrhthymias.

atrial fibrillation PACs, heart, cardiology, primary care, caffeine, neurology

Premature cardiac contractions—known to initiate paroxysms of atrial fibrillation—are not brought on by chronic consumption of caffeine, a California team reports.

Writing in the Journal of the American Heart Association, Gregory Marcus, MD, MAS of the University of California San Francisco and colleagues analyzed the caffeinated beverage consumption of 1,416 individuals.

Their caffeinated beverage drinking habits were assessed and they were given 24-hour Holter monitoring.

The electro cardiogram data was reviewed to look for PACs and ventricular ectopic beats (PVCs) per hour and correlated with cafeeine consumption times.

They were also categorized by demographics, body mass index, caloric intake, diabetes status, smoking status and alcohol consumption habits.

Twenty-eight individuals had to be excluded from the study because they had persistent atrial fibrillation throughout the study.

Greater than 60% of participants reported driving at least one caffeinated beverage daily. One study shortcoming is that they asked only about coffee, tea, and chocolate drinks—not sodas.

“Though caffeine consumption has long been related to cardiac ectopy and arrhythmias by anecdote and biological plausibility, few studies have demonstrated any relationship,” the team noted.

Despite the lack of research, clinicians often recommend that patients avoid caffeine.

Though they were not able to determine whether there was a maximum threshold for safe caffeine consumption, “our findings suggest that clinical recommendations advising against the regular consumptions of caffeinated products to prevent cardiac ectopy and arrhythmia should be reconsidered,” the team concluded.

“Our results support a long history of data from both experimental and observational trials indicating that moderate consumption of caffeine is not associated with cardiac ectopy and extend that evidence from predominately arrhythmia patients to a community‐based cohort,” they wrote.

Related Videos
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.